David Younger on how synthetic biology helps to identify molecular glues

David Younger is a bioengineer and started his biotech journey
directly after his PhD. David’s scientific research was focused
on the application of synthetic biology techniques for
high-throughput screening of protein-protein interactions. In
2017 David co-founded A-Alpha Bio as a spin-out from the
University of Washington. A-Alpha Bio applies synthetic biology
to reprogram yeast mating and generate high quality protein
interaction data at scale. Its AlphaSeq technology enables
high-throughput, quantitative characterization of protein–protein
binding interactions without requiring purified recombinant
proteins to identify molecular glues.